Loading...
Projects / Programmes source: ARIS

Kirurgija raka prebavil - primerjava želodčnega in kolorektalnega raka (Slovene)

Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   

Code Science Field
B007  Biomedical sciences  Medicine (human and vertebrates) 
B200  Biomedical sciences  Cytology, oncology, cancerology 
Keywords
cancer, stomach, colorectal, surgery, radical operation (R0,D2/3), 5-year survival, comparison, prognostic factors
Evaluation (rules)
source: COBISS
Researchers (11)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  08616  PhD Matej Bračko  Oncology  Researcher  1996 - 2001  197 
2.  12719  Milič Čalič  Oncology  Researcher  1998 - 2001  39 
3.  06758  PhD Franc Jelenc  Oncology  Researcher  1998 - 2001  278 
4.  13839  MSc Robert Juvan  Oncology  Researcher  1996 - 2001  188 
5.  04376  PhD Janez Lamovec  Oncology  Researcher  1996 - 2001  239 
6.  17685  Vanda Majnik    Researcher  1998 - 2001 
7.  10614  PhD Mirko Omejc  Oncology  Researcher  1998 - 2001  259 
8.  19204  Aljaž Repše  Oncology  Researcher  1999 - 2001  15 
9.  01528  PhD Stanislav Repše  Oncology  Head  1996 - 2001  308 
10.  19205  PhD Zdravko Štor  Oncology  Researcher  1996 - 2001  196 
11.  06763  MSc Bojan Žakelj  Oncology  Researcher  1998 - 2001  45 
Organisations (2)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  77,480 
2.  0302  Institute of Oncology Ljubljana  Ljubljana  5055733000  15,471 
Abstract
The object of the project is to examine our hypothesis on not signifficantly different prognosis in gastric cancer patients (GCP) and in colorectal cancer patients (CRP) in the equal UICC pTNM stage undergoing potentially curative operation (R0 resection, D2/3 lymphadenectomy). The present belief in better prognosis for radically operated colorectal cancer patients is being examinated. In the 5-year period (Jan.1/1993 - Dec. 31/1997) 391/498 GCP and 742/780 CRP undervent resection (R0,R1,R2). All important anamnestic, clinical, intraoperative, pathological and follow-up data were prospective collected in standard protocols and in PC. Resectabillity GCP 77,5%, CRP 95,1%. UICC pTNM stage in GCP: S0 1,3%, SIa 14,8%, S1b 15,9%, SII 19,9%, SIIIa 24,1%, SIIIb 15,6%, SIV 7,9%, unnovn 0,5%. UICC pTNM stage in CRP: S0 1,9%, SIa 2,7%, SIb 8,7%, SII 33,5%, SIIIa 18,9%, SIIIb 15,5%, SIV 19,3%. Postoperative hospital mortallity rate: GCP 3,8%, CRP 7,3%. In April 1999 survival data for these patients per Dec. 31st 1998 wil by available in Cancer Registry of Slovenia. The analysis of all important factors in comparison with 5-year survival will be made by statistic methods, thus our hypothesis may be proved. Large number of operated patients and standardised operations assure the reliability of the analysis.
Views history
Favourite